Brand Names not allowed on formulary.

Posted in Latest News on July 23, 2019.

The Board of Optometry met on July 18, 2019 in Orlando regarding adding Rocklatan to the formulary; the board dismissed the request as name-brands cannot be added, and the combined ingredients are already on the formulary.



More Latest News

Electronic Prescribing Requirements
October 21, 2019

Click here for the new requirements requiring prescribers to generate and transmit all prescriptions electronically Continue reading


Important Notice regarding Dextenza and Klarity-C
October 15, 2019

The Board of Optometry has approved Dextenza (dexamethasone ophthalmic insert) 0.4 mg and Klarity-C (cyclosporine) 0.1% for addition to Rule 64B13-18.002. Continue reading